These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 38995526)

  • 1. Vaginal irritation testing-prospects of human organotypic vaginal tissue culture models.
    Ayehunie S; Landry T; Armento A
    In Vitro Cell Dev Biol Anim; 2024 Jun; 60(6):569-582. PubMed ID: 38995526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Qualification of a non-animal vaginal irritation method admitted as nonclinical assessment model (NAM) in the Incubator Phase of the United States Food and Drug Administration (US FDA) Medical Devices Development Tool (MDDT).
    Costin GE; Hill E; Brown J; Clippinger AJ
    Toxicol In Vitro; 2020 Feb; 62():104680. PubMed ID: 31626901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organotypic human vaginal-ectocervical tissue model for irritation studies of spermicides, microbicides, and feminine-care products.
    Ayehunie S; Cannon C; Lamore S; Kubilus J; Anderson DJ; Pudney J; Klausner M
    Toxicol In Vitro; 2006 Aug; 20(5):689-98. PubMed ID: 16309879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaginal irritation models: the current status of available alternative and in vitro tests.
    Costin GE; Raabe HA; Priston R; Evans E; Curren RD
    Altern Lab Anim; 2011 Sep; 39(4):317-37. PubMed ID: 21942546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of an in vitro alternative assay method for vaginal irritation.
    Ayehunie S; Cannon C; Larosa K; Pudney J; Anderson DJ; Klausner M
    Toxicology; 2011 Jan; 279(1-3):130-8. PubMed ID: 20937349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro skin irritation: facts and future. State of the art review of mechanisms and models.
    Welss T; Basketter DA; Schröder KR
    Toxicol In Vitro; 2004 Jun; 18(3):231-43. PubMed ID: 15046769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testing vaginal irritation with the Hen’s Egg Test-Chorioallantoic Membrane assay.
    Palmeira-de-Oliveira R; Monteiro Machado R; Martinez-de-Oliveira J; Palmeira-de-Oliveira A
    ALTEX; 2018; 35(4):495-503. PubMed ID: 29534246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personal and Clinical Vaginal Lubricants: Impact on Local Vaginal Microenvironment and Implications for Epithelial Cell Host Response and Barrier Function.
    Wilkinson EM; Łaniewski P; Herbst-Kralovetz MM; Brotman RM
    J Infect Dis; 2019 Nov; 220(12):2009-2018. PubMed ID: 31539059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperosmolal vaginal lubricants markedly reduce epithelial barrier properties in a three-dimensional vaginal epithelium model.
    Ayehunie S; Wang YY; Landry T; Bogojevic S; Cone RA
    Toxicol Rep; 2018; 5():134-140. PubMed ID: 29854584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal toxicity studies of a gel formulation of native pokeweed antiviral protein.
    D'Cruz OJ; Waurzyniak B; Uckun FM
    Toxicol Pathol; 2004; 32(2):212-21. PubMed ID: 15200159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HSP27 as a biomarker for predicting skin irritation in human skin and reconstructed organotypic skin model.
    Chen H; Li S; Meng T; Zhang L; Dai T; Xiang Q; Su Z; Zhang Q; Huang Y
    Toxicol Lett; 2014 Apr; 226(2):124-31. PubMed ID: 24503015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-animal testing strategies for assessment of the skin corrosion and skin irritation potential of ingredients and finished products.
    Robinson MK; Cohen C; de Fraissinette Ade B; Ponec M; Whittle E; Fentem JH
    Food Chem Toxicol; 2002 May; 40(5):573-92. PubMed ID: 11955663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety study of an antimicrobial peptide lactocin 160, produced by the vaginal Lactobacillus rhamnosus.
    Dover SE; Aroutcheva AA; Faro S; Chikindas ML
    Infect Dis Obstet Gynecol; 2007; 2007():78248. PubMed ID: 18273406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial on the effectiveness and safety of 5 water-based personal lubricants.
    Palacios S; Hood S; Abakah-Phillips T; Savania N; Krychman M
    J Sex Med; 2023 Mar; 20(4):498-506. PubMed ID: 36781402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro assessment of eye irritancy using the Reconstructed Human Corneal Epithelial SkinEthic HCE model: application to 435 substances from consumer products industry.
    Cotovio J; Grandidier MH; Lelièvre D; Bremond C; Amsellem C; Maloug S; Ovigne JM; Loisel-Joubert S; Lee AV; Minondo AM; Capallere C; Bertino B; Alépée N; Tinois-Tessonneaud E; de Fraissinette Ade B; Meunier JR; Leclaire J
    Toxicol In Vitro; 2010 Mar; 24(2):523-37. PubMed ID: 19913609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Vaginal Lubricants on In-Vitro Progressive Spermatozoa Motility.
    Wilson SL; Adam JK; Krishna SBN
    Afr J Reprod Health; 2017 Sep; 21(3):96-101. PubMed ID: 29624933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consumer protection provided by the European medical device and cosmetic legislation for condoms and lubricants.
    Desmedt B; Vanhamme M; Vanhee C; Rogiers V; Deconinck E
    Regul Toxicol Pharmacol; 2019 Apr; 103():106-112. PubMed ID: 30659873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety assessment of Salicylic Acid, Butyloctyl Salicylate, Calcium Salicylate, C12-15 Alkyl Salicylate, Capryloyl Salicylic Acid, Hexyldodecyl Salicylate, Isocetyl Salicylate, Isodecyl Salicylate, Magnesium Salicylate, MEA-Salicylate, Ethylhexyl Salicylate, Potassium Salicylate, Methyl Salicylate, Myristyl Salicylate, Sodium Salicylate, TEA-Salicylate, and Tridecyl Salicylate.
    Cosmetic Ingredient Review Expert Panel
    Int J Toxicol; 2003; 22 Suppl 3():1-108. PubMed ID: 14617432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation of the chemical-induced eye injury using a weight-of-evidence (WoE) battery of 21 artificial neural network (ANN) c-QSAR models (QSAR-21): part I: irritation potential.
    Verma RP; Matthews EJ
    Regul Toxicol Pharmacol; 2015 Mar; 71(2):318-30. PubMed ID: 25497990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human small intestinal organotypic culture model for drug permeation, inflammation, and toxicity assays.
    Markus J; Landry T; Stevens Z; Scott H; Llanos P; Debatis M; Armento A; Klausner M; Ayehunie S
    In Vitro Cell Dev Biol Anim; 2021 Feb; 57(2):160-173. PubMed ID: 33237403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.